Literature DB >> 20838493

Glanzmann's thrombasthenia and molecular mimicry.

Viroj Wiwanitkit1.   

Abstract

Entities:  

Year:  2010        PMID: 20838493      PMCID: PMC2927795          DOI: 10.4103/0971-6866.64942

Source DB:  PubMed          Journal:  Indian J Hum Genet        ISSN: 1998-362X


× No keyword cloud information.
Sir, I recently read with great interest the current publication of Ghosh et al.[1] It is interesting that the antiplatelet antibodies can also be present in patients who had not received any platelet transfusion. In this regard, the molecular mimicry might be the responsible mechanism as the author’s proposal. Definitely, there must be a previous stimutation, which is assumed to be an autoantigen that can lead to the generation of antiplatelet antibodies.[2] The other proposal regarding the possibility of another mechanism seems to be a weaker hypothesis. Considering that the author had performed well control on the laboratory analysis system, there should not be other interference on the analysis.
  2 in total

1.  Antiplatelet antibodies in cases of Glanzmann's thrombasthenia with and without a history of multiple platelet transfusion.

Authors:  Kanjaksha Ghosh; B Kulkarni; S Shetty; S Nair
Journal:  Indian J Hum Genet       Date:  2009-01

2.  Further characterization of the thrombasthenia-related idiotype OG. Antiidiotype defines a novel epitope(s) shared by fibrinogen B beta chain, vitronectin, and von Willebrand factor and required for binding to beta 3.

Authors:  Y Gruel; E Brojer; D J Nugent; T J Kunicki
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.